CIK 0001789972
- Non-accelerated filer
- Smaller reporting company
Cullinan Therapeutics, Inc.
Sign in to watch- Ticker
- CGEM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813879991
- Phone
- +1 617-410-4650
- Business address
- ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
- Former names
- Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $222,000
- in 2 filings, $222K under 10b5-1 plans
Net −$222,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-24 | AHMED NADIM President and CEO | Sale | −13,515 | $14.47 | $196K | 390,803 |
| 2026-02-20 | AHMED NADIM President and CEO | Sale | −16,381 | $13.62 | $223K | 404,318 |
| 2026-02-18 | AHMED NADIM President and CEO | Grant or award · Stock Option (Right to Buy) | +828,000 | 828,000 | ||
| 2025-12-23 | AHMED NADIM President and CEO | Sale | −9,922 | $10.01 | $99K | 420,699 |
| 2025-02-25 | AHMED NADIM President and CEO | Sale | −12,529 | $8.53 | $107K | 430,621 |
| 2025-02-19 | AHMED NADIM President and CEO | Grant or award | +180,000 | 443,150 | ||
| 2025-02-19 | AHMED NADIM President and CEO | Grant or award · Stock Option (Right to Buy) | +360,000 | 360,000 | ||
| 2024-12-24 | AHMED NADIM President and CEO | Sale | −8,400 | $11.87 | $100K | 263,150 |
| 2024-02-22 | AHMED NADIM President and CEO | Grant or award | +160,000 | 271,550 | ||
| 2024-02-22 | AHMED NADIM President and CEO | Grant or award · Stock Option (Right to Buy) | +320,000 | 320,000 | ||
| 2023-12-26 | AHMED NADIM President and CEO | Sale | −4,272 | $9.24 | $39K | 111,550 |
| 2023-06-28 | AHMED NADIM President and CEO | Sale | −759 | $11.40 | $9K | 115,822 |
| 2023-05-23 | AHMED NADIM President and CEO | Sale | −707 | $9.15 | $6K | 116,581 |
| 2023-04-25 | AHMED NADIM President and CEO | Sale | −716 | $10.59 | $8K | 117,288 |
| 2023-03-23 | AHMED NADIM President and CEO | Sale | −706 | $10.51 | $7K | 118,004 |
| 2023-02-22 | AHMED NADIM President and CEO | Grant or award | +109,000 | 118,710 | ||
| 2023-02-22 | AHMED NADIM President and CEO | Grant or award · Stock Option (Right to Buy) | +211,000 | 211,000 | ||
| 2022-06-30 | AHMED NADIM President and CEO | Grant or award | +1,620 | $10.90 | $18K | 9,710 |
| 2022-06-06 | AHMED NADIM President and CEO | Purchase | +8,090 | $12.40 | $100K | 8,090 |
| 2022-03-05 | AHMED NADIM President and CEO | Grant or award · Performance Stock Unit | +215,000 | 215,000 |
Page 1 of 2 · 21 trades